157 related articles for article (PubMed ID: 37816983)
21. The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity.
Karban A; Feldman T; Waterman M; Leiba R; Efrati E
Medicine (Baltimore); 2016 Dec; 95(51):e5611. PubMed ID: 28002332
[TBL] [Abstract][Full Text] [Related]
22. Bone density improves with disease remission in patients with inflammatory bowel disease.
Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseases.
Krela-Kaźmierczak I; Szymczak-Tomczak A; Łykowska-Szuber L; Wysocka E; Michalak M; Stawczyk-Eder K; Waszak K; Linke K; Eder P
Adv Clin Exp Med; 2018 Apr; 27(4):449-453. PubMed ID: 29558031
[TBL] [Abstract][Full Text] [Related]
24. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
25. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study.
Golbahar J; Hamidi A; Aminzadeh MA; Omrani GR
Bone; 2004 Sep; 35(3):760-5. PubMed ID: 15336613
[TBL] [Abstract][Full Text] [Related]
26. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases.
Ezzat Y; Hamdy K
Int J Rheum Dis; 2010 Aug; 13(3):259-65. PubMed ID: 20704624
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis.
Targownik LE; Bernstein CN; Nugent Z; Leslie WD
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):278-85. PubMed ID: 23103821
[TBL] [Abstract][Full Text] [Related]
28. Associations between vitamin D, bone mineral density, and the course of inflammatory bowel disease in Polish patients.
Ratajczak AE; Szymczak-Tomczak A; Michalak M; Rychter AM; Zawada A; Dobrowolska A; Krela-Kaźmierczak I
Pol Arch Intern Med; 2022 Dec; 132(12):. PubMed ID: 36026616
[TBL] [Abstract][Full Text] [Related]
29. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD.
Villadsen MM; Bünger MH; Carstens M; Stenkjaer L; Langdahl BL
Osteoporos Int; 2005 Apr; 16(4):411-6. PubMed ID: 15300362
[TBL] [Abstract][Full Text] [Related]
30. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal assessment of bone mineral density in children and adolescents with inflammatory bowel disease.
Schmidt S; Mellström D; Norjavaara E; Sundh V; Saalman R
J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):511-8. PubMed ID: 22688562
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.
Kaya G; Koçak E; Akbal E; Taş A; Köklü S
South Med J; 2011 Nov; 104(11):747-51. PubMed ID: 22024784
[TBL] [Abstract][Full Text] [Related]
33. Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.
Krela-Kaźmierczak I; Kaczmarek-Ryś M; Szymczak A; Michalak M; Skrzypczak-Zielińska M; Drwęska-Matelska N; Marcinkowska M; Eder P; Łykowska-Szuber L; Wysocka E; Linke K; Słomski R
Calcif Tissue Int; 2016 Dec; 99(6):616-624. PubMed ID: 27639566
[TBL] [Abstract][Full Text] [Related]
34. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
35. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
[TBL] [Abstract][Full Text] [Related]
36. Bone mineral density in spanish children at the diagnosis of inflammatory bowel disease.
Masip E; Donat E; Polo Miquel B; Ribes-Koninckx C
Arch Osteoporos; 2021 Jun; 16(1):96. PubMed ID: 34145515
[TBL] [Abstract][Full Text] [Related]
37. Discriminatory ability of calcaneal quantitative ultrasound in the assessment of bone status in patients with inflammatory bowel disease.
Turk N; Kastelan D; Cukovic-Cavka S; Kraljevic I; Korsic M; Vucelic B
Ultrasound Med Biol; 2007 Jun; 33(6):863-9. PubMed ID: 17434664
[TBL] [Abstract][Full Text] [Related]
38. Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.
Schmidt S; Mellström D; Norjavaara E; Sundh SV; Saalman R
Inflamm Bowel Dis; 2009 Dec; 15(12):1844-50. PubMed ID: 19408319
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound measurements of calcaneus for estimation of skeletal status in patients with inflammatory bowel disease.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 1999 Aug; 34(8):790-7. PubMed ID: 10499480
[TBL] [Abstract][Full Text] [Related]
40. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
